The differential capture of HER2-positive exosomes between BC and HD samples suggests that SP-IRIS could potentially serve as a sensitive method for detecting elevated levels of HER2-positive exosomes in plasma, which may correlate with HER2-positive breast cancer status. Here, ERBB2 is linked to breast carcinoma.